TY - JOUR
T1 - Factores de riesgo cardiovascular en Estados Unidos y México
T2 - Comparación de los estudios hable y enasem
AU - Vintimilla, Raúl
AU - Reyes, Miguel
AU - Johnson, Leigh
AU - Hall, James
AU - O’bryant, Sid
N1 - Funding Information:
HABLE is funded by the National Institute on Aging, which belongs to the National Institutes of Health of the United States, with grant number R01AG054073. MHAS is partially funded by the National Institutes of Health/National Institute on Aging (NIHR01AG018016) and by INEGI.
Funding Information:
The research herein reported was supported by the National Institute on Aging, which is part of the National Institutes of Health. The content is the responsibility of the authors and does not necessarily represent the official vision of the National Institutes of Health. The research team would like to thank Fort Worth local community and the HABLE and MHAS participants. The data and documentation files are for public use and are available at www.ENASEM.org HABLE is funded by the National Institute on Aging, which belongs to the National Institutes of Health of the United States, with grant number R01AG054073. MHAS is partially funded by the National Institutes of Health/National Institute on Aging (NIH R01AG018016) and by INEGI.
Publisher Copyright:
© 2019 Academia Nacional de Medicina de México, A.C.. Published by Permanyer.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Introduction: In the United States, information on the Mexican-American population is available through the Health and Aging Brain among Latino Elders (HABLE) study; in Mexico, the results of the Mexican Health and Aging Study (MHAS) are available. Objective: To compare the prevalence of cardiovascular risk factors between men and women of the HABLE and MHAS studies. Method: The prevalence of hypertension, diabetes, hypercholesterolemia and abdominal obesity was transversely analyzed in 559 HABLE participants and compared with data from 13,663 MHAS participants. The comparison was made using Student’s t-test and the chi-square test, according to the type of variable. Results: The analysis showed that the prevalence of hypertension (50 %, 95 % CI = 41.8-51.8), diabetes (35.5 %, 95 % CI = 27.6-43.8) and abdominal obesity (59.3 %, 95 % CI = 50.5-68.1) were significantly higher in HABLE males, whereas females had a higher prevalence of diabetes (36.8 %, 95 % CI = 32.2-41.5) and abdominal obesity (89.6 %, 95 % CI = 86.6-92.5). Hypercholesterolemia had a higher prevalence in MHAS females (53.3 %, 95 % CI = 50.3-56.2). Conclusion: The prevalence of cardiovascular risk factors was higher in Mexican-American HABLE participants, than in Mexican MHAS participants.
AB - Introduction: In the United States, information on the Mexican-American population is available through the Health and Aging Brain among Latino Elders (HABLE) study; in Mexico, the results of the Mexican Health and Aging Study (MHAS) are available. Objective: To compare the prevalence of cardiovascular risk factors between men and women of the HABLE and MHAS studies. Method: The prevalence of hypertension, diabetes, hypercholesterolemia and abdominal obesity was transversely analyzed in 559 HABLE participants and compared with data from 13,663 MHAS participants. The comparison was made using Student’s t-test and the chi-square test, according to the type of variable. Results: The analysis showed that the prevalence of hypertension (50 %, 95 % CI = 41.8-51.8), diabetes (35.5 %, 95 % CI = 27.6-43.8) and abdominal obesity (59.3 %, 95 % CI = 50.5-68.1) were significantly higher in HABLE males, whereas females had a higher prevalence of diabetes (36.8 %, 95 % CI = 32.2-41.5) and abdominal obesity (89.6 %, 95 % CI = 86.6-92.5). Hypercholesterolemia had a higher prevalence in MHAS females (53.3 %, 95 % CI = 50.3-56.2). Conclusion: The prevalence of cardiovascular risk factors was higher in Mexican-American HABLE participants, than in Mexican MHAS participants.
KW - Cardiovascular disease
KW - Mexican-Americans
KW - Mexico
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=85086163182&partnerID=8YFLogxK
U2 - 10.24875/GMM.M19000316
DO - 10.24875/GMM.M19000316
M3 - Article
C2 - 32026882
AN - SCOPUS:85086163182
VL - 156
SP - 16
EP - 20
JO - Gaceta medica de Mexico
JF - Gaceta medica de Mexico
SN - 0016-3813
IS - 1
ER -